These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 9413199

  • 21. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
    Ford JM, Prozialeck WC, Hait WN.
    Mol Pharmacol; 1989 Jan; 35(1):105-15. PubMed ID: 2563302
    [Abstract] [Full Text] [Related]

  • 22. Antimutagenicity of phenothiazine-metal co-ordination complexes in chemically induced mutagenesis.
    Tanaka M, Molnár J, Kidd S.
    Anticancer Res; 1997 Jan; 17(1A):381-5. PubMed ID: 9066681
    [Abstract] [Full Text] [Related]

  • 23. Antiplasmid activity: loss of bacterial resistance to antibiotics.
    Molnár J, Földeák S, Nakamura MJ, Rausch H, Domonkos K, Szabó M.
    APMIS Suppl; 1992 Jan; 30():24-31. PubMed ID: 1295542
    [Abstract] [Full Text] [Related]

  • 24. Reversal of ABCB1-related Multidrug Resistance of Colonic Adenocarcinoma Cells by Phenothiazines.
    Takács D, Csonka Á, Horváth Á, Windt T, Gajdács M, Riedl Z, Hajós G, Amaral L, Molnár J, Spengler G.
    Anticancer Res; 2015 Jun; 35(6):3245-51. PubMed ID: 26026084
    [Abstract] [Full Text] [Related]

  • 25. The in vitro antitumor assay of "half-mustard type" phenothiazines in screens of AIDS-related leukemia and lymphomas.
    Wuonola MA, Palfreyman MG, Motohashi N, Kawase M, Gabay S, Molnár J.
    Anticancer Res; 1997 Jun; 17(5A):3425-9. PubMed ID: 9413181
    [Abstract] [Full Text] [Related]

  • 26. Reversal of multidrug resistance in mouse lymphoma cells by phenothiazines.
    Molnar J, Molnar A, Mucsi I, Pinter O, Nagy B, Varga A, Motohashi N.
    In Vivo; 2003 Jun; 17(2):145-9. PubMed ID: 12792975
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
    Bisi A, Meli M, Gobbi S, Rampa A, Tolomeo M, Dusonchet L.
    Bioorg Med Chem; 2008 Jul 01; 16(13):6474-82. PubMed ID: 18522868
    [Abstract] [Full Text] [Related]

  • 34. Synthesis and biochemical characterization of new phenothiazines and related drugs as MDR reversal agents.
    Schmidt M, Teitge M, Castillo ME, Brandt T, Dobner B, Langner A.
    Arch Pharm (Weinheim); 2008 Oct 01; 341(10):624-38. PubMed ID: 18816589
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Trifluoperazine and its metal complexes inhibit the Moloney leukemia virus reverse transcriptase.
    Nacsa J, Nagy L, Molnar J, Molnar J.
    Anticancer Res; 1998 Oct 01; 18(3A):1373-6. PubMed ID: 9673343
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. New phenothiazine-type multidrug resistance modifiers: anti-MDR activity versus membrane perturbing potency.
    Hendrich AB, Wesołowska O, Motohashi N, Molnár J, Michalak K.
    Biochem Biophys Res Commun; 2003 May 02; 304(2):260-5. PubMed ID: 12711308
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.